drugset / Trial / NCT01037816

FS-67 in the Treatment of Pediatric Patients With Ankle Sprain

NCT01037816 ↗

Phase 4 Completed 252 enrolled Hisamitsu Pharmaceutical Co., Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

The objective of this study is assess the efficacy and safety of single and multiple applications of the FS-67 patch in the treatment of ankle sprain in pediatric population (ages 13-17).

Timeline

Start
2009-12
Primary completion
2010-11
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator FS-67 Patch Unknown — Topical

Indications

No indication recorded.